
Trial of ankylosing spondylitis drug has positive results
In the trial (COAST-V), Taltz met the primary and all key secondary endpoints and demonstrated a statistically significant improvement in the signs and symptoms of AS when compared to placebo. Spondylitis is an inflammatory condition […]